CacheTech Inc’s AbbVie ABBV Stock Holding History

CacheTech Inc’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$645K	Buy	2,965 +195	+7%	+$43.3K	0.12%	102
2025 Q4	$633K	Sell	2,770 -162	-6%	-$36.9K	0.12%	115
2025 Q3	$679K	Sell	2,932 -394	-12%	-$80.2K	0.14%	85
2025 Q2	$617K	Sell	3,326 -1,613	-33%	-$300K	0.11%	89
2025 Q1	$1.03M	Sell	4,939 -339	-6%	-$65.9K	0.2%	66
2024 Q4	$938K	Buy	5,278 +565	+12%	+$104K	0.18%	67
2024 Q3	$931K	Sell	4,713 -301	-6%	-$56.2K	0.2%	62
2024 Q2	$860K	Buy	+5,014	New	+$831K	0.2%	58

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CacheTech Inc's ABBV Position: Q1 2026 in Review

CacheTech Inc increased its AbbVie (ABBV) stake by 7% in Q1 2026, buying an estimated $43.3K and bringing the position to 2,965 shares worth $645K. The position accounts for 0.12% of the portfolio, ranked #102.

CacheTech Inc first reported a position in ABBV in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.03M in Q1 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

CacheTech Inc held 2,965 shares of AbbVie worth $645K as of Q1 2026.
CacheTech Inc bought 195 AbbVie shares in Q1 2026, an estimated $43.3K.
AbbVie made up 0.12% of CacheTech Inc's portfolio in Q1 2026, its #102 holding.
CacheTech Inc first reported a position in AbbVie in Q2 2024 and has held it in 8 quarters since.
CacheTech Inc's AbbVie position peaked at $1.03M in Q1 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on CacheTech Inc's 13F filing for Q1 2026, filed 12 May 2026.